Health FDA backs away from RFK Jr.’s claims about drug’s promise for autism patients 365daily.net March 10, 2026 Food and Drug Administration Commissioner Marty Makary said in September he was changing leucovorin’s label because it could help “hundreds of thousands” of children with the neurological condition. Continue Reading Previous: Banyon Spends Nearly $40M on Tampa Office ComplexNext: I worked a corporate job for 8.5 years. I quit over a text message. Related Stories Health The new surgeon general nominee has a MAHA problem 365daily.net May 2, 2026 Health Drugmaker files emergency appeal to restore abortion pill access 365daily.net May 2, 2026 Health Centers for Medicare and Medicaid Services exposes doctors’ Social Security numbers 365daily.net May 2, 2026